[1]
Erhart, C.-C., Cefalì M., Mangan , D., Kasenda , B. and Wannesson, L. 2024. Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis. Swiss Medical Weekly. 154, 7 (Jul. 2024), 3695. DOI:https://doi.org/10.57187/s.3695.